Treatment effect of maximum performance speech therapy for individuals with Parkinson's disease and dysarthria

...................................................................................................iii LITERATURE REVIEW.......................................................................................1 ICF Model for Rehabilitation...............................................................................2 Parkinson’s Disease..............................................................................................3 Hypokinetic Dysarthria.........................................................................................4 Lee Silverman Voice Treatment..............................................................................5 Modifications to LSVT TM Protocol.......................................................................7 METHODS......................................................................................................12 Subjects......................................................................................................12 Design ........................................................................................................12 Procedures...................................................................................................13 Data Analysis...............................................................................................15 RESULTS......................................................................................................17 Experimental Questions...................................................................................18 Reliability...................................................................................................25 DISCUSSION.................................................................................................27 Limitations..................................................................................................33 Future Studies .............................................................................................35 SUMMARY....................................................................................................36 REFERENCES................................................................................................37 APPENDIX A: CMOST OUTCOME MEASURES PROTOCOL.....................................43 APPENDIX B: CMOST THERAPY PROTOCOL........................................................46 VITA..............................................................................................................48